Govt announces revamped pharmaceuticals technology upgradation assistance scheme

March 11, 2024 | Monday | News

Contributing to pharmaceutical industry’s growth and compliance with global manufacturing standards

image credit- shutterstock

image credit- shutterstock

The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, has announced the Revamped Pharmaceuticals Technology Upgradation Assistance (RPTUAS) Scheme. It is a significant step in government’s efforts to help upgrade the technological capabilities of the pharmaceutical industry and ensure its alignment with the global standards.

The approval of the revised Scheme follows a comprehensive review by the Scheme Steering Committee in light of the requirements of the revised Schedule-M of the Drugs and Cosmetics Rule, 1945 as issued by the Department of Health & Family Welfare on 28 December 2023.

The revised guideline aims to support the pharmaceutical industry's up-gradation to the Revised Schedule-M & WHO-GMP standards, enhancing the quality and safety of pharmaceutical products manufactured in the country.

Reflecting a more inclusive approach, eligibility for the PTUAS has been expanded beyond Micro, Small and Medium Enterprises (MSMEs) to include any pharmaceutical manufacturing unit with a turnover of less than Rs 500 crore that requires technology and quality upgradation. Preference remains for MSMEs, supporting smaller players in achieving high-quality manufacturing standards.

The scheme introduces a robust verification mechanism through a Project Management Agency, ensuring transparency, accountability and the efficient allocation of resources.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy